These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 35095994)
21. Integrated Bioinformatics and Experimental Analysis Identified TRIM28 a Potential Prognostic Biomarker and Correlated with Immune Infiltrates in Liver Hepatocellular Carcinoma. Han J; Wang Y; Zhou H; Ai S; Wan D Comput Math Methods Med; 2022; 2022():6267851. PubMed ID: 36238495 [TBL] [Abstract][Full Text] [Related]
22. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis. Wang R; Hu X; Liu X; Bai L; Gu J; Li Q PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762 [TBL] [Abstract][Full Text] [Related]
23. CDCA8 as an independent predictor for a poor prognosis in liver cancer. Shuai Y; Fan E; Zhong Q; Chen Q; Feng G; Gou X; Zhang G Cancer Cell Int; 2021 Mar; 21(1):159. PubMed ID: 33685433 [TBL] [Abstract][Full Text] [Related]
24. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma. Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863 [TBL] [Abstract][Full Text] [Related]
25. Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma. Kui XY; Gao Y; Liu XS; Zeng J; Yang JW; Zhou LM; Liu XY; Zhang Y; Zhang YH; Pei ZJ Front Oncol; 2022; 12():809847. PubMed ID: 35957868 [TBL] [Abstract][Full Text] [Related]
26. FANCI is Associated with Poor Prognosis and Immune Infiltration in Liver Hepatocellular Carcinoma. Hou Y; Li J; Yu A; Deng K; Chen J; Wang Z; Huang L; Ma S; Dai X Int J Med Sci; 2023; 20(7):918-932. PubMed ID: 37324186 [No Abstract] [Full Text] [Related]
27. ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma. Deng T; Liu Y; Zhuang J; Tang Y; Huo Q Front Oncol; 2022; 12():632042. PubMed ID: 35515103 [TBL] [Abstract][Full Text] [Related]
28. Identification of ABCC5 Among ATP-Binding Cassette Transporter Family as a New Biomarker for Hepatocellular Carcinoma Based on Bioinformatics Analysis. Qiu Y; Li H; Xie J; Qiao X; Wu J Int J Gen Med; 2021; 14():7235-7246. PubMed ID: 34737618 [TBL] [Abstract][Full Text] [Related]
29. GIV is a promising novel poor prognostic factor in liver hepatocellular carcinoma. Zou Z; Sun Y; Wang L; Ma S; Sun C; Zhou Y; Yang G Medicine (Baltimore); 2022 Aug; 101(32):e29645. PubMed ID: 35960100 [TBL] [Abstract][Full Text] [Related]
30. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma. Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618 [TBL] [Abstract][Full Text] [Related]
31. Upregulation Mitochondrial Carrier 1 (MTCH1) Is Associated with Cell Proliferation, Invasion, and Migration of Liver Hepatocellular Carcinoma. Chen G; Mo S; Yuan D Biomed Res Int; 2021; 2021():9911784. PubMed ID: 34195286 [TBL] [Abstract][Full Text] [Related]
32. Overexpressed Histocompatibility Minor 13 was Associated with Liver Hepatocellular Carcinoma Progression and Prognosis. Zong RQ; Zhang HY; Li XY; Li YR; Chen Y Genet Res (Camb); 2022; 2022():7067743. PubMed ID: 36262249 [TBL] [Abstract][Full Text] [Related]
33. CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target. Jiang Q; Kuai J; Jiang Z; Que W; Wang P; Huang W; Ding W; Zhong L Front Immunol; 2023; 14():1158360. PubMed ID: 37483608 [TBL] [Abstract][Full Text] [Related]
34. Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma. Li D; Yu T; Han J; Xu X; Wu J; Song W; Liu G; Zhu H; Zeng Z Front Mol Biosci; 2021; 8():799651. PubMed ID: 35111813 [TBL] [Abstract][Full Text] [Related]
35. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma. Liang Y; Su S; Lun Z; Zhong Z; Yu W; He G; Wang Q; Wang J; Huang S Front Mol Biosci; 2022; 9():1012505. PubMed ID: 36267158 [No Abstract] [Full Text] [Related]
36. ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC. Zhou L; Fu Z; Wang S; Jia J; Cheng Y; Zheng Y; Zhang N; Lu W; Yao Z Front Oncol; 2022; 12():875097. PubMed ID: 35586489 [TBL] [Abstract][Full Text] [Related]
37. Aberrantly high DEPDC1B expression leads to poor prognosis in patients with lower-grade gliomas. Liu ZD; Liang WJ; Cheng XB; Qian RJ; Gao YZ Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):7813-7826. PubMed ID: 36394729 [TBL] [Abstract][Full Text] [Related]
38. A novel microRNA signature predicts survival in liver hepatocellular carcinoma after hepatectomy. Fu Q; Yang F; Xiang T; Huai G; Yang X; Wei L; Yang H; Deng S Sci Rep; 2018 May; 8(1):7933. PubMed ID: 29785036 [TBL] [Abstract][Full Text] [Related]
39. Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment. Jiang Z; Xing C; Wang P; Liu X; Zhong L Front Cell Dev Biol; 2021; 9():748269. PubMed ID: 34938730 [No Abstract] [Full Text] [Related]
40. Downregulated Ferroptosis-Related Gene STEAP3 as a Novel Diagnostic and Prognostic Target for Hepatocellular Carcinoma and Its Roles in Immune Regulation. Yan Y; Liang Q; Xu Z; Huang J; Chen X; Cai Y; Peng B; Yi Q Front Cell Dev Biol; 2021; 9():743046. PubMed ID: 34790664 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]